Use of cardiovascular medical therapy among patients undergoing coronary artery bypass graft surgery: Results from the ROSETTA-CABG Registry

Canadian Journal of Cardiology

Volumn 22, Issue 10, 2006, Pages 841-847

  Okrainec, Karen ^a   Pilote, Louise ^b   Platt, Robert ^c   Eisenberg, Mark J ^d  

^a MCGILL UNIVERSITY   (Canada)

^b MCGILL UNIVERSITY HEALTH CENTRE   (Canada)

^c MONTREAL CHILDREN S HOSPITAL   (Canada)

^d MCGILL UNIVERSITY   (Canada)

Author keywords

Cardiovascular medical therapy; Coronary Artery bypass graft; Discharge; Secondary prevention

Indexed keywords

ACETYLSALICYLIC ACID; ANGIOTENSIN RECEPTOR ANTAGONIST; ANTILIPEMIC AGENT; BETA ADRENERGIC RECEPTOR BLOCKING AGENT; CALCIUM CHANNEL BLOCKING AGENT; CLOPIDOGREL; DIPEPTIDYL CARBOXYPEPTIDASE INHIBITOR; NITRATE; WARFARIN; ANTICOAGULANT AGENT; ANTITHROMBOCYTIC AGENT; CARDIOVASCULAR AGENT;

ADULT; AGED; ARTICLE; CLINICAL TRIAL; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; CORONARY ARTERY BYPASS GRAFT; DRUG USE; FEMALE; HEART INFARCTION; HEART LEFT VENTRICLE EJECTION FRACTION; HOSPITAL ADMISSION; HOSPITAL DISCHARGE; HUMAN; HYPERLIPIDEMIA; HYPERTENSION; LOGISTIC REGRESSION ANALYSIS; MAJOR CLINICAL STUDY; MALE; MULTICENTER STUDY; OBESITY; PHARMACEUTICAL CARE; POSTOPERATIVE CARE; PROSPECTIVE STUDY; TREADMILL EXERCISE; ANALYSIS OF VARIANCE; CORONARY ARTERY ATHEROSCLEROSIS; EUROPE; EXERCISE TEST; FOLLOW UP; HEART MUSCLE ISCHEMIA; HEART STROKE VOLUME; MIDDLE AGED; NORTH AMERICA; PAKISTAN; PATHOPHYSIOLOGY; POSTOPERATIVE COMPLICATION; REGISTER; TREATMENT OUTCOME;

AGED; ANALYSIS OF VARIANCE; ANGIOTENSIN-CONVERTING ENZYME INHIBITORS; ANTICOAGULANTS; ANTILIPEMIC AGENTS; CARDIOVASCULAR AGENTS; CORONARY ARTERIOSCLEROSIS; CORONARY ARTERY BYPASS; EUROPE; EXERCISE TEST; FEMALE; FOLLOW-UP STUDIES; HUMANS; MALE; MIDDLE AGED; MYOCARDIAL ISCHEMIA; NORTH AMERICA; PAKISTAN; PLATELET AGGREGATION INHIBITORS; POSTOPERATIVE COMPLICATIONS; PROSPECTIVE STUDIES; REGISTRIES; STROKE VOLUME; TREATMENT OUTCOME;

EID: 33749069692     PISSN: 0828282X     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0828-282X(06)70302-6     Document Type: Article

References (28)

1. Eleven-year survival in the Veterans Administration randomized trial of coronary bypass surgery for stable angina. The Veterans Administration Coronary Artery Bypass Surgery Cooperative Study Group. N Engl J Med 1984;311:1333-9.
2. Hultgren HN, Peduzzi P, Detre K, Takaro T. The 5 year effect of bypass surgery on relief of angina and exercise performance. Circulation 1985;72:V79-83.
3. Yusuf S, Zucker D, Peduzzi P, et al. Effect of coronary artery bypass graft surgery on survival: Overview of 10-year results from randomised trials by the Coronary Artery Bypass Graft Surgery Trialists' Collaboration. Lancet 1994;344:563-70. (Erratum in 1994;344:1446).
4. Weintraub WS, Clements SD Jr, Crisco LV, et al. Twenty-year survival after coronary artery surgery: An institutional perspective from Emory University. Circulation 2003;107:1271-7.
5. Bourassa MG, Campeau L, Lesperance J. Effects of bypass surgery on the coronary circulation: Incidence and effects of vein graft occlusion. Cardiovasc Clin 1977;8:107-18.
6. Kloster FE, Kremkau EL, Ritzmann LW, Rahimtoola SH, Rosch J, Kanarek PH. Coronary bypass for stable angina: A prospective randomized study. N Engl J Med 1979;300:149-57.
7. Antithrombotic Trialists' Collaboration. Collaborative meta-analysis of randomised trials of antiplatelet therapy for prevention of death, myocardial infarction, and stroke in high risk patients. BMJ 2002;324:71-86. (Erratum in 2002;324:141).
8. Collaborative overview of randomised trials of antiplatelet therapy - I: Prevention of death, myocardial infarction, and stroke by prolonged antiplatelet therapy in various categories of patients. Antiplatelet Trialists' Collaboration. BMJ 1994;308:81-106. (Erratum in 1994;308:1540).
9. Mangano DT; Multicenter Study of Perioperative Ischemia Research Group. Aspirin and mortality from coronary bypass surgery. N Engl J Med 2002;347:1309-17.
10. The effect of aggressive lowering of low-density lipoprotein cholesterol levels and low-dose anticoagulation on obstructive changes in saphenous-vein coronary-artery bypass grafts. The Post Coronary Artery Bypass Graft Trial Investigators. N Engl J Med 1997;336:153-62. (Erratum in 1997;337:1859).
11. Eagle KA, Guyton RA, Davidoff R, et al. ACC/AHA guidelines for coronary artery bypass graft surgery: A report of the American College of Cardiology/American Heart Association Task Force on Practice Guidelines (committee to revise the 1991 guidelines for coronary artery bypass graft surgery). American College of Cardiology/American Heart Association. J Am Coll Cardiol 1999;34:1262-347.
12. Ryan TJ, Antman EM, Brooks NH, et al. 1999 update: ACC/AHA guidelines for the management of patients with acute myocardial infarction: Executive summary and recommendations: A report of the American College of Cardiology/American Heart Association Task Force on Practice Guidelines (committee on management of acute myocardial infarction). Circulation 1999;100:1016-30.
13. Sacks FM, Pfeffer MA, Moye LA, et al. The effect of pravastatin on coronary events after myocardial infarction in patients with average cholesterol levels. Cholesterol and Recurrent Events Trial investigators. N Engl J Med 1996;335:1001-9.
14. Gavaghan TP, Gebski V, Baron DW. Immediate postoperative aspirin improves vein graft patency early and late after coronary artery bypass graft surgery. A placebo-controlled, randomized study. Circulation 1991;83:1526-33.
15. White CW, Gobel FL, Campeau L, et al; Post Coronary Artery Bypass Graft Trial Investigators. Effect of an aggressive lipid-lowering strategy on progression of atherosclerosis in the left main coronary artery from patients in the Post Coronary Artery Bypass Graft Trial. Circulation 2001;104:2660-5.
16. Effect of metoprolol CR/XL in chronic heart failure: Metoprolol CR/XL Randomised Intervention Trial in congestive Heart Failure (MERIT-HF). Lancet 1999;353:2001-7.
17. Hjalmarson A, Elmfeldt D, Herlitz J, et al. Effect on mortality of metoprolol in acute myocardial infarction. A double-blind randomised trial. Lancet 1981;2:823-7.
18. A randomized trial of propranolol in patients with acute myocardial infarction. I. Mortality results. JAMA 1982;247:1707-14.
19. Yusuf S, Sleight P, Pogue J, Bosch J, Davies R, Dagenais G. Effects of an angiotensin-converting-enzyme inhibitor, ramipril, on cardiovascular events in high-risk patients. The Heart Outcomes Prevention Evaluation Study Investigators. N Engl J Med 2000;342:145-53. (Erratum in 2000;342:1376, 2000;342:748).
20. Spencer F, Scleparis O, Goldberg RJ, Yarzebski J, Lessard D, Gore JM, Decade-long trends (1986 to 1997) in the medical treatment of patients with acute myocardial infarction: A community-wide perspective. Am Heart J 2001;142:594-603.
21. Eisenberg MJ, Califf RM, Cohen EA, Adelman AG, Mark DB, Topol EJ. Use of evidence-based medical therapy in patients undergoing percutaneous coronary revascularization in the United States, Europe, and Canada. Coronary Angioplasty Versus Excisional Atherectomy Trial (CAVEAT-I) and Canadian Coronary Atherectomy Trial (CCAT) investigators. Am J Cardiol 1997;79:867-72.
22. Allen JK, Blumenthal RS, Margolis S, Young DR. Status of secondary prevention in patients undergoing coronary revascularization. Am J Cardiol 2001;87:1203-6: A7.
23. Rogers WJ, Bowlby LJ, Chandra NC, et al. Treatment of myocardial infarction in the United States (1990 to 1993). Observations from the National Registry of Myocardial Infarction. Circulation 1994;90:2103-14.
24. Hasdai D, Lerman A, Grill DE, Rihal CS, Homes DR Jr. Medical therapy after successful percutaneous coronary revascularization. Ann Intern Med 1999;130:108-15.
25. Pearson TA, Peters TD. The treatment gap in coronary artery disease and heart failure: Community standards and the post-discharge patient. Am J Cardiol 1997;80(8B):45H-52H.
26. Montague T, Cox J, Kramer S, et al. Improving cardiovascular outcomes in Nova Scotia (ICONS): A successful public-private partnership in primary healthcare. Hosp Q 2003;6:32-8.
27. McAlister FA, Taylor L, Teo KK, et al. The treatment and prevention of coronary heart disease in Canada: Do older patients receive efficacious therapies? The Clinical Quality Improvement Network (CQIN) Investigators. J Am Geriatr Soc 1999;47:811-8.
28. Montague T, Taylor L, Martin S, et al. Can practice patterns and outcomes be successfully altered? Examples from cardiovascular medicine. The Clinical Quality Improvement Network (CQIN) Investigators. Can J Cardiol 1995;11:487-92.